Acute Myeloid Leukaemia
Acute Myeloid Leukaemia (AML) is a type of cancer that starts in the blood-forming cells of the bone marrow and progresses rapidly, leading to an increase in abnormal white blood cells.
Myeloid Malignancies: PF-08046040/SEA-CD70
We are studying the safety of a new treatment for patients with myeloid malignancies. This research aims to understand how well the treatment is tolerated by patients.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Myelodysplastic Syndrome
Myelodysplastic Syndrome (MDS) is a group of disorders caused by poorly formed or dysfunctional blood cells, leading to ineffective blood cell production and a risk of developing acute leukaemia.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Universitair Medisch Centrum Utrecht
University Medical Center (UMC) Utrecht Cancer Center
De Bilt, Netherlands
Sponsor: Seagen Inc.
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.